UnitedHealth Group Incorporated (UNH)
Here is What to Know Beyond Why UnitedHealth Group Incorporated (UNH) is a Trending Stock
UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
UnitedHealth: Inflection Confirmation Imminent
UnitedHealth Group Incorporated navigated a turbulent 2025 with management changes, mispriced costs, and a surging medical cost ratio, but revenue growth remained robust. We expect 2026 EPS guidance in the high teens, signaling a double-digit rebound off 2025's $16.25–$16.50 floor, with confirmation of inflection imminent at the upcoming earnings. Dividend growth and a 2.8% yield provide income while awaiting margin recovery; buybacks are paused but likely to resume as cash flow improves.
UnitedHealth Could Re-Take Its All-Time High In 2026
Recently the U.S. Senate approved another round of Affordable Care Act (ACA) subsidy extensions. Trump said he "might" veto the subsidy extensions, but he did not conclusively say he would. UnitedHealth's stock got beaten down partially because the subsidies were expected to expire. The subsidies did in fact expire, but were re-instated and extended. Just recently, the company re-affirmed its full year earnings guidance for 2026, a number that implies significant growth over the trailing 12 month period.
Senate report says UnitedHealth used aggressive tactics to boost medicare payments, WSJ reports
Health insurer UnitedHealth Group used aggressive tactics to gather diagnoses that can boost Medicare Advantage payments, the Wall Street Journal reported on Monday, citing a U.S. Senate committee investigating the company's practices.
UnitedHealth Group deployed aggressive tactics to collect payment-boosting diagnoses for its Medicare Advantage members, a Senate committee investigating the company's practices said
Sen. Chuck Grassley launched an investigation last year following Wall Street Journal reports examining the company's Medicare Advantage practices.
This ETF Is Proof That the Healthcare Rebound Is Real
With well-publicized losses for companies including UnitedHealth Group NYSE: UNH, Elevance Health NYSE: ELV, and Wegovy and Ozempic maker Novo Nordisk NYSE: NVO, the healthcare sector failed to outperform the broad market last year.
How Corporate Security Has Changed a Year After UnitedHealth Killing
Spending on executive protection is up, and it isn't all bodyguards and trained drivers.
UnitedHealth Sinks 34.5% in a Year: Buy the Dip Before Q4 Earnings?
UNH shares are down 34.5% in a year as costs and margins bite, with Q4 earnings and 2026 guidance set to test whether value is emerging.
Why UnitedHealth Group (UNH) Outpaced the Stock Market Today
In the most recent trading session, UnitedHealth Group (UNH) closed at $336.4, indicating a +1.91% shift from the previous trading day.
Chart Master: UnitedHealthcare might be setting up for a bearish-to-bullish reversal
Carter Worth, Worth Charting, joins 'Fast Money' to talk what's ahead for UnitedHealthcare.
UnitedHealth has regulatory headwinds to get through in 2026, says DCLA's Sarat Sethi
Sarat Sethi, DCLA, joins 'Closing Bell Overtime' to talk stocks that are struggling heading into 2026 including UnitedHeath, SalesForce, and Amazon.
UNH vs. ELV: Which Managed Care Stock Has the Edge Today?
Elevance Health is edging past UnitedHealth as Carelon's growth, strategic exits and a cheaper valuation shape a stronger near-term setup.
